Australia markets closed

ABBV Jun 2024 155.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
14.810.00 (0.00%)
As of 03:38PM EDT. Market open.
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    PCE reading, Microsoft, Alphabet jump on earnings: Yahoo Finance

    Investors are digesting the Fed's preferred inflation measure after the release of the Personal Consumption Expenditures (PCE) index.Big Tech is coming to the rescue on Wall Street. Microsoft (MSFT) and Alphabet (GOOGL, GOOG) are jumping following their latest earning reports. Both companies topped expectations and were helped by their AI businesses. The news comes after a rough day for stocks, with a weaker-than-expected GDP report and earnings from companies such as Meta (META), sending markets deep in the red. Today, we will hear from big names, including ExxonMobil (XOM), Chevron (CVX), Colgate-Palmolive (CL), and AbbVie (ABBV). Yahoo Finance trending tickers include Intel (INTC), Snap (SNAP), and Roku (ROKU). Key guests include:9 a.m. ET - Brian Rose -UBS Global Wealth Management Senior US Economist10:40 a.m. ET - Chris Peterson, Newell Brands CEO11:20 a.m. ET - Patrick Gelsinger, Intel CEO

  • GuruFocus.com

    AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges

    Comprehensive Analysis of AbbVie's Latest Financial Performance

  • Investor's Business Daily

    AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title

    AbbVie stock was muted Friday after beating first-quarter expectations as Humira sales continue falling. Skyrizi is catching up, though.